Interleukin 28B gene, Class II cytokine receptors (IL28B). Detection of mutation g.39738787C>T (rs12979860, gene regulatory region)

The marker is associated with genetic resistance to viral infections. It is investigated to predict the efficacy of Hepatitis C treatment with Ribavirin (Rebetol) and PEG-interferon (PegIntron) drugs. OMIM: *607402. dbSNP: rs12979860

Within 5 days. The specified time does not include the day of biomaterial collection